PROPHASE LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.42 USD | +2.07% |
|
+15.07% | +19.91% |
| 04-16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
| 04-16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
Chart calendar ProPhase Labs, Inc.
a327fc0f27fa3a936292e8d96.mGZ26qU6oC2TzakbokhxL-yRP9Wgy8tW6YC5M0jxdFA.yQUDuvFZxmDDneFfzx0oR57oSYXs5q0JjMXSBnCbHz3rVTfe9nzBGau_-A~c7d3124b081a1d2ce2cb3e7e267c8aef
Upcoming events on ProPhase Labs, Inc.
Past events on ProPhase Labs, Inc.
| 01/05/2024 19:30 | Planet MicroCap Showcase |
| 15/03/2024 15:00 | Q4 2023 Earnings Call |
| 15/03/2024 12:00 | Q4 2023 Earnings Release |
| 09/11/2023 16:00 | Q3 2023 Earnings Call |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 19/10/2023 16:30 | ThinkEquity Conference |
| 10/08/2023 16:00 | Q2 2023 Earnings Call |
| 10/08/2023 13:00 | Q2 2023 Earnings Release |
| 16/06/2023 21:00 | Annual General Meeting |
| 13/06/2023 18:00 | Diamond Equity Research Emerging Growth Invitational Investor Conference |
| 11/05/2023 16:00 | Q1 2023 Earnings Call |
| 11/05/2023 13:00 | Q1 2023 Earnings Release |
| 26/04/2023 18:30 | Planet MicroCap Showcase |
| 28/03/2023 16:00 | Q4 2022 Earnings Call |
| 28/03/2023 13:00 | Q4 2022 Earnings Release |
| 22/03/2023 | Roadshow |
| 14/03/2023 17:00 | Premiere Global Pathology Conference - Abstract #: 1946 |
| 11/01/2023 | Roadshow - Renmark |
| 07/12/2022 19:30 | Planet MicroCap Showcase |
| 14/11/2022 20:00 | FY Investor Summit |
Past dividends on ProPhase Labs, Inc.
| 23/05/2022 | 0.3 USD |
| 27/02/2022 | 0.3 USD |
| 23/05/2021 | 0.3 USD |
| 01/12/2019 | 0.25 USD |
| 08/01/2019 | 0.25 USD |
| 05/06/2018 | 1 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,88 | 14,5 14,9 -2.27% | 79,0 68,9 14.74% | 123 121 1.08% | 45,2 51,6 -12.29% | 54,8 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -2,09 -1,18 -78.13% | 9,80 5,73 70.93% | 23,6 29,2 -19.32% | -21,6 -15,0 -44.25% | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -2,33 -1,07 -116.98% | 5,31 5,06 4.81% | 22,9 28,6 -19.89% | -22,8 -15,9 -42.98% | -14,9 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -2,13 -1,18 -79.48% | 6,27 4,56 37.52% | 18,5 21,4 -13.74% | -16,8 -12,8 -30.68% | -14,9 |
|
EPS USD | Released Forecast Spread | -0,27 | -0,18 -0,10 -80% | 0,40 0,29 40.35% | 1,02 1,12 -8.93% | -0,98 -0,74 -32.43% | -0,83 |
| Announcement Date | 25/03/20 | 31/03/21 | 30/03/22 | 28/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 45,2 35,0 29.02% | 47,5 32,1 48.3% | 29,1 23,3 24.72% | 24,2 21,4 12.95% | 21,8 20,5 6.39% | 19,3 15,1 27.62% | 13,2 14,1 -6.53% | 8,37 13,1 -35.95% | 4,35 10,7 -59.29% | 9,86 | 11,2 | 14,9 | 18,8 | 31,1 |
|
EBIT Million USD | Released Forecast Spread | 13,7 9,61 42.32% | 16,1 7,27 122.18% | 10,6 3,56 197.81% | 1,95 4,59 -57.45% | -5,09 0,56 -1010.55% | 0,88 -1,47 159.36% | -4,66 -2,17 -114.56% | -6,48 -3,04 -113.44% | -11,4 -4,99 -127.45% | -7,25 | -7,25 | -6,65 | -6,05 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,62 9,38 2.6% | 15,9 7,20 120.91% | 10,4 3,46 201.11% | 1,78 4,60 -61.39% | -5,19 0,50 -1145.12% | 0,56 -1,54 136.65% | -4,91 -2,27 -116.38% | -6,79 -3,14 -116.43% | -11,7 -5,19 -124.72% | -7,45 | -7,45 | -6,85 | -6,25 | |
|
Net income Million USD | Released Forecast Spread | 10,6 8,88 19.28% | 12,5 7,20 73.48% | 7,45 2,96 151.77% | 0,97 3,73 -74.01% | -2,44 0,50 -592.25% | 0,55 -1,54 135.74% | -3,44 -2,27 -51.48% | -5,14 -3,14 -63.99% | -8,75 -5,19 -68.58% | -7,45 | -7,45 | -6,85 | -6,25 | |
|
EPS USD | Released Forecast Spread | 0,66 0,57 15.79% | 0,68 0,47 44.68% | 0,40 0,16 150% | 0,06 0,19 -68.42% | -0,08 0,03 -420% | 0,03 -0,10 130% | -0,20 -0,14 -42.86% | -0,30 -0,20 -53.85% | -0,51 -0,26 -96.15% | -0,28 | -0,25 | -0,17 | -0,13 | 0,10 |
| Announcement Date | 30/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 28/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 15/03/24 | - | - | - | - | - |
| 07/05/2024 21:05 | OPKO HEALTH, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VIJAYA DIAGNOSTIC CENTRE LIMITED: Q4 2024 Earnings Release |
| 07/05/2024 | RADNET, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | SYNLAB AG: Q1 2024 Earnings Release |
| 08/05/2024 | FLEURY S.A.: Q1 2024 Earnings Release |
| 09/05/2024 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
| 09/05/2024 | DR. LAL PATHLABS LIMITED: Q4 2024 Earnings Release |
| 09/05/2024 | BML, INC.: Q4 2023 Earnings Release |
| 13/05/2024 | METROPOLIS HEALTHCARE LIMITED: Q4 2024 Earnings Release (Projected) |
| 24/07/2024 | DR. LAL PATHLABS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for ProPhase Labs, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRPH Stock
- Calendar ProPhase Labs, Inc.
